Embryyo

Embryyo is a med-tech innovation studio dedicated to advancing the medical devices industry. The company focuses on front-end innovation, opportunity research, intellectual property creation, and product engineering to develop transformative medical devices. Their goal is to enhance patient care, reduce costs for providers and payers, and deliver significant returns for stakeholders. Embryyo collaborates with leading multinational corporations to support early-stage technology development, patent generation, and proof-of-concept demonstrations. They specialize in identifying unmet clinical needs and engineering innovative solutions, including device design upgrades and novel inserter tools for implantable devices. Their portfolio includes medical devices in interventional oncology, surgery, wearables, and drug delivery, integrating AI and advanced technology to improve disease management and treatment. The company partners with organizations like Vyome Holdings to develop AI-enabled smart medical devices, targeting the global market and focusing on women's health through specialized accelerators. Embryyo's mission is to advance the frontiers of medicine, creating multidimensional value that drives improvements in patient care and stakeholder impact.

• Employees 12
• Founded 2014
• Annual Revenue $5054000